Detalhe da pesquisa
1.
The relationship between pathological brain activity and functional network connectivity in glioma patients.
J Neurooncol
; 166(3): 523-533, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38308803
2.
Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials: findings from an international, multidisciplinary working group.
Lancet Oncol
; 24(2): e86-e95, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36725153
3.
Single-arm studies involving patient-reported outcome data in oncology: a literature review on current practice.
Lancet Oncol
; 24(5): e197-e206, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142381
4.
Regional healthy brain activity, glioma occurrence and symptomatology.
Brain
; 145(10): 3654-3665, 2022 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36130310
5.
Cellular Substrates of Functional Network Integration and Memory in Temporal Lobe Epilepsy.
Cereb Cortex
; 32(11): 2424-2436, 2022 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34564728
6.
Is the EORTC QLQ-C30 emotional functioning scale appropriate as an initial screening measure to identify brain tumour patients who may possibly have a mood disorder?
Psychooncology
; 31(6): 995-1002, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35083812
7.
Neurocognitive impairment and patient-proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients.
Qual Life Res
; 31(11): 3253-3266, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35982202
8.
Development of an EORTC questionnaire measuring instrumental activities of daily living (IADL) in patients with brain tumours: phase I-III.
Qual Life Res
; 30(5): 1491-1502, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33496902
9.
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium.
Lancet Oncol
; 21(2): e83-e96, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32007209
10.
Effectiveness and tolerability of lacosamide as add-on therapy in patients with brain tumor-related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES).
Epilepsia
; 61(4): 647-656, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32329527
11.
Postoperative oscillatory brain activity as an add-on prognostic marker in diffuse glioma.
J Neurooncol
; 147(1): 49-58, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31953611
12.
Healthcare utilization and productivity loss in glioma patients and family caregivers: the impact of treatable psychological symptoms.
J Neurooncol
; 147(2): 485-494, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32172441
13.
Advance care planning in glioblastoma patients: development of a disease-specific ACP program.
Support Care Cancer
; 28(3): 1315-1324, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31243585
14.
Evaluation of the content coverage of questionnaires containing basic and instrumental activities of daily living (ADL) used in adult patients with brain tumors.
J Neurooncol
; 143(1): 1-13, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30887244
15.
Efficacy and cost-utility of the eHealth application 'Oncokompas', supporting patients with incurable cancer in finding optimal palliative care, tailored to their quality of life and personal preferences: a study protocol of a randomized controlled trial.
BMC Palliat Care
; 18(1): 85, 2019 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31647011
16.
The association between preoperative edema and postoperative cognitive functioning and health-related quality of life in WHO grade I meningioma patients.
Acta Neurochir (Wien)
; 161(3): 579-588, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30756243
17.
Working plan for the use of patient-reported outcome measures in adults with brain tumours: a Response Assessment in Neuro-Oncology (RANO) initiative.
Lancet Oncol
; 19(3): e173-e180, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29508764
18.
Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial.
Lancet Oncol
; 19(9): 1170-1179, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30115593
19.
Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review.
Lancet Oncol
; 19(9): e459-e469, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30191850
20.
The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033.
Acta Neuropathol
; 135(4): 601-615, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29368212